Elena MyasoedovaMD MyasoedovaElena
5 years 7 months ago
🔥 Increased baseline prevalence and 40% higher risk of developing #Multimorbidity after #RA incidence/index vs general population @CrowsonCindy @JohnDavisIII #MayoClinicRheumatology @jrheum @NIAMSFunding @NIH https://t.co/8GolTowAGm
Dr. John Cush RheumNow
5 years 7 months ago
Consults in Cars--Is this the future of telehealth?
https://t.co/INbKZ3xxty https://t.co/9Wj2eXy71l
Dr. John Cush RheumNow
5 years 7 months ago
Download Available--TNF Inhibitor -Cycle TNFi or Switch MOA?
https://t.co/PgmTDYltpX
Dr. John Cush RheumNow
5 years 7 months ago
RWCS Highlights - Day 3
-Psoriatic Arthritis
-Evidence Based Medicine: Diet and Rheumatic Diseases
-Hot topics in Allergy/Immunology
-Pediatric Rheumatology – past, present, and future
https://t.co/CaKAyhxId3 https://t.co/5m882bcTOo
Botson et al has reported that the combination of methotrexate (MTX) and IV pegloticase is safe and effective in patients with uncontrolled gout.
This exploratory, open-label clinical trial screened 17 patients and treated 14 patients (all men, 49.3 ± 8.7 years) with IV pegloticase with MTX (15 mg/week) and folic acid (1 mg/day) 4 weeks prior to and throughout pegloticase treatment.
Dr. John Cush RheumNow
5 years 7 months ago
Prospective study of 162 early RA pts looked at Xrays (baseline & 5 yrs). RF & ESR predicted erosion & JSN progression; CCP predicted erosions; Smoking & high DAS28 > 5.1 predicted progression of erosions. Obesity negatively predicted JSN progression https://t.co/fue121hHVw
Dr. John Cush RheumNow
5 years 7 months ago
Study of Systemic Sclerosis patients from the EUSTAR database: shows of the 144 with anti-PM/Scl+ Abs, there was an increased risk of muscle involvement, ILD, calcinosis and dermatomyositis; muscle involvement had a more severe disease phenotype. https://t.co/ORA2y1BWgn
Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.
Dr. John Cush RheumNow
5 years 7 months ago
Join us at RheumNow Live next month in Texas or virtually! CME credits available.
https://t.co/uwxOVh142F https://t.co/58BvLesevP
Dr. John Cush RheumNow
5 years 7 months ago
RheumNow Podcast: 2021 RWCS Review
Drs. Jack Cush and Arthur Kavanaugh recap highlights from the 2021 Rheumatology Winter Clinical Symposium.
https://t.co/iyYaO3NOBS
Dr. John Cush RheumNow
5 years 7 months ago
Video---Proposal of Novel Multimodal Outcome Instrument for Assessing SLE Activity--RWCS 2021 Poster Session by Dr. Barbara Jacobs, UC-San Diego
https://t.co/3H4iNssyrZ
Dr. John Cush RheumNow
5 years 7 months ago
RWCS Highlights - Day 2 by Dr. Rachel Tate ( @uptotate)
-What’s new in Spondyloarthritis
-Osteoporosis and Beyond
-Immunologic basis and clinical characteristics
https://t.co/q4lI2BYhfz https://t.co/Q79CHaQrHf
Dr. John Cush RheumNow
5 years 7 months ago
Wheel of Misfortune
RWCS 2021 Poster Session by Dr. Phildrich Teh, Scripps Institute
https://t.co/vaw6FcY8r8
Dr. Rachel Tate uptoTate
5 years 7 months ago
In addition to a safe space to visit w/ pt, remember to get consent for telehealth visit, document others present w/ patient, & document appropriateness for the type of visit (pt is 80 or avoidance of in person visit due to COVID, etc) @alvinwellsmd #RWCS2021, @RheumNow @RWCSmtg https://t.co/G22LYxg5po
Dr. Rachel Tate uptoTate
5 years 7 months ago
Do you know about FDA approved wearable devices? Check them out here! @alvinwellsmd @RheumNow @RWCSmtg #RWCS2021 #RWCS
https://t.co/hgOxOzshcP
